SlideShare a Scribd company logo
2
Most read
3
Most read
10
Most read
Detection of production of
Reactive Oxygen Species by
SPIO
Preliminary Data
Background
• Since the production of ROS in the plaque
would have significant effect on the
vulnerability of the plaque.
• We wanted to check if the SPIO would
produce ROS.
Principle
• Any event of phagocytosis is immediately
followed by a transient release of super oxide due
to the assembly of the NADPH oxidase against the
plasma membrane. Subsequently the oxidase
translocates onto the phagosomes containing the
SPIO to produce intracellular ROS.
• Thus an early extra cellular secretion of super
oxide is detectable (using luminol) soon after
phagocytosis and a later event of intracellular
secretion is measurable using DCFDA dye .
Method
∀ • The suspension of SPIO (1.25-10 uL) was added
to macrophages (1x10*4/well in 96 well plates).
Cells were incubated for 1 h and washed to
remove extra cellular FDIO. For each dose three
wells were tested.
Isoluminol substrate was added and super oxide
induced luminescence measured at 15, 30 and 45
min intervals using a luminometer.
Results
• SPIO was internalized by macrophages as
early as 60 min after addition.
• Uptake was followed by release of super
oxide for all four doses tested.
Super oxide was released by SPIO at all
doses tested (1.25-10 ul)
Dosage of SPIO-1.25mL
0
500
1000
1500
2000
2500
3000
3500
15min 30min 45min NOSPIO
Sample1
Sample2
Sample3
Dosage at 2.5mL
0
500
1000
1500
2000
2500
3000
3500
15min 30min 45min
Sample1
Sample2
Sample3
Dosage at 5mL
0
500
1000
1500
2000
2500
3000
15min 30min 45min
Sample1
Sample2
Sample3
Dosage at 10mL
0
200
400
600
800
1000
1200
1400
1600
1800
15min 30min 45min
Sample1
Sample2
Sample3
Detection of intracellular ROS
with DCFDA dye
• Particles ingested by macrophages are enclosed
within a phagosome and the NADPH oxidase
assembles on these phagosomes to generate super
oxide. Super oxide dismutates into hydrogen
peroxide rapidly within the macrophage. This
H2O2 is detected by a fluorescent dye DCFDA.
DCFDA is by itself non-fluorescent. When it
enters a viable cell it is hydrolyzed by esterases
into DCF which is then oxidized by H2O2 to yield
a green fluorescence. This is measured by
fluorometer.
Method
∀• The suspension of SPIO (1.25-10 uL) was
added to macrophages (1x10*4/well in 96
well plates). Cells were incubated for 24 h
and washed to remove extracellular SPIO.
For each dose three wells were tested.
∀• DCFDA substrate was added and read for
intracellular fluorescence using a
fluorometer at 485nm/538 nm.
Results
∀•Uptake was followed by release of H2O2
for all four doses tested.
∀•H2O2 was released by SPIO at all doses
tested (1.25-10 ul/)
∀•Note untreated macrophages have a
background fluorescence of < 2 AFU
Dosage at 1.25mL
0
5
10
15
20
25
30
30min 180min
Sample1
Sample2
Sample3
Dosage of 2.5mL
0
5
10
15
20
25
30
30min 180min
Sample1
Sample2
Sample3
At 5mL
0
5
10
15
20
25
30
30min 180min
Sample1
Sample2
Sample3
At 10mL
0
5
10
15
20
25
30
30min 180min
Sample1
Sample2
Sample3
Detection of macrophage
viability after ROS production
• Viable macrophages convert the Alamar
blue dye into an orange colored product
measurable in a Elisa reader. AB is a widely
used method to measure viability.
• The hypothesis we are testing is that cells
that make ROS may die and lose viability.
Thus if SPIO stimulates ROS within the
cells does it lead to cell death over time ??
Method
∀ • The suspension of SPIO (1.25-10 uL) was added
to macrophages (1x10*4/well in 96 well plates).
Cells were incubated for 1 h or 24 h and washed to
remove extracellular SPIO. For each dose three
wells were tested.
∀ • AB dye at 20% volume was added to the
macrophage plate and incubated for 4 h at 37o
C
and 5% Co2. They were read for viability using
an Elisa at 570 nm
Results
• Both SPIO treated as well as untreated
macrophages had same level of viability as
shown in the following slide at 24 h post
SPIO treatment.
Viability values with alamar blue
0.585
0.59
0.595
0.6
0.605
0.61
0.615
0.62
0.625
0.63
1.25mL 2.5mL 5mL 10mL Untreated
Sample1
Sample2
Sample3
Future plan
• As ox-LDL is know to produce ROS, we
would like to see the same effect in the
presence of our SPIO.

More Related Content

PPTX
ANTISENSE OLIGONUCLEOTIDES.pptx
PPTX
Pharmacogenetics and Pharmacogenomics
PPTX
Mapping Techniques - Fluorescent in situ Hybridization(FISH) and Sequence Tag...
PPTX
Apoptosis assays detection and methods
PPTX
Pharmacogenetics by dr.mahi
PPT
Genomics & Proteomics Based Drug Discovery
PPTX
Applications of microarray
PPTX
Gene delivery system
ANTISENSE OLIGONUCLEOTIDES.pptx
Pharmacogenetics and Pharmacogenomics
Mapping Techniques - Fluorescent in situ Hybridization(FISH) and Sequence Tag...
Apoptosis assays detection and methods
Pharmacogenetics by dr.mahi
Genomics & Proteomics Based Drug Discovery
Applications of microarray
Gene delivery system

What's hot (20)

PDF
Structural genomics
PDF
Cell viability assays
PDF
Gene mapping
PPTX
Cytotoxicity Study.pptx
PPTX
proteomics
PPTX
Comet assay
PPTX
Apoptosis extrinsic pathway
PPTX
Applications of proteomic sciences
PPTX
Proteomics ppt
PPTX
Recent advances in gene therapy
PPTX
Nucleic acid microarray
PPTX
SAGE (Serial analysis of Gene Expression)
PDF
Gene mapping
PPTX
Express sequence tags
PPT
Dna methylation
PPTX
RECOMBINANT DNA TECHNOLOGY - seminar.pptx
PPT
Xenotransplantation
Structural genomics
Cell viability assays
Gene mapping
Cytotoxicity Study.pptx
proteomics
Comet assay
Apoptosis extrinsic pathway
Applications of proteomic sciences
Proteomics ppt
Recent advances in gene therapy
Nucleic acid microarray
SAGE (Serial analysis of Gene Expression)
Gene mapping
Express sequence tags
Dna methylation
RECOMBINANT DNA TECHNOLOGY - seminar.pptx
Xenotransplantation
Ad

Viewers also liked (19)

PPT
222 animal models of heart attack
PPT
Detection of vulnerable plaque by nis
PPT
Vp watch editorial - v2 n4- 2002
PPT
225 animal models of heart attack part 2
PPT
Definitions of arterial remodeling
PPT
Vp watch editorial_slide 25short-
PPT
228 crp, is it a risk factor not a risk marker
PPT
Vulnerable patient talk in poland
PPT
Dr n's presentation at nano vivo seminar
PPT
Updated power point presentation of the vulnerable patient manuscript
PPT
237 vulnerable plaque in esc 2002
222 animal models of heart attack
Detection of vulnerable plaque by nis
Vp watch editorial - v2 n4- 2002
225 animal models of heart attack part 2
Definitions of arterial remodeling
Vp watch editorial_slide 25short-
228 crp, is it a risk factor not a risk marker
Vulnerable patient talk in poland
Dr n's presentation at nano vivo seminar
Updated power point presentation of the vulnerable patient manuscript
237 vulnerable plaque in esc 2002
Ad

Similar to Detection of production of reactive oxygen (20)

PPT
Detection of production preliminary
PPT
Acc presentation lipid coated(2)
PPT
Acc presentation lipid coated(2)
PPT
159 spio uptake by macrophages
PPT
PDF
cytopreparation techniques part 2
PPTX
Intracellular Reactive Oxygen Species (ROS) Detection Assay Kit | TCI Chemicals
DOCX
Research Paper 2012
PPTX
Liposomes 141009105743-conversion-gate02
PPTX
In-vitro evaluation techniques of anticancer, anti oxidant, anti microbial
PPTX
Vital staining ppt notes
PDF
Advantages And Disadvantages Of Reverse Sequence Syphilis...
PPT
Rflp marker
PPTX
Antiioxidant Assay.pptx
PDF
Daily changes in the phosphoproteome of the dinoflagellate Lingulodinium
DOCX
PDF
Spectrophotometric determination of some organophosphorus
PDF
Sanchez_2015_Research
DOCX
ApoB Sequencing
Detection of production preliminary
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
159 spio uptake by macrophages
cytopreparation techniques part 2
Intracellular Reactive Oxygen Species (ROS) Detection Assay Kit | TCI Chemicals
Research Paper 2012
Liposomes 141009105743-conversion-gate02
In-vitro evaluation techniques of anticancer, anti oxidant, anti microbial
Vital staining ppt notes
Advantages And Disadvantages Of Reverse Sequence Syphilis...
Rflp marker
Antiioxidant Assay.pptx
Daily changes in the phosphoproteome of the dinoflagellate Lingulodinium
Spectrophotometric determination of some organophosphorus
Sanchez_2015_Research
ApoB Sequencing

More from Society for Heart Attack Prevention and Eradication (20)

PPTX
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
PPTX
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
PPTX
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
PPTX
AHA SHAPE Symposium 2017 Dr. Yen Presentation
PDF
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
PPT
Vulnerable plaque vulnerable patient
PPT
Vulnerable patient slides without movies
PPT
PPT
Vp watch editorial_slide25short-
PPT
Vp meeting orlando2003_new template
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
Vulnerable plaque vulnerable patient
Vulnerable patient slides without movies
Vp watch editorial_slide25short-
Vp meeting orlando2003_new template

Recently uploaded (20)

PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
1. Basic chemist of Biomolecule (1).pptx
PPT
HIV lecture final - student.pptfghjjkkejjhhge
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
Neuropathic pain.ppt treatment managment
PPTX
y4d nutrition and diet in pregnancy and postpartum
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
PPTX
antibiotics rational use of antibiotics.pptx
PPTX
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
PPT
Infections Member of Royal College of Physicians.ppt
PPTX
Acid Base Disorders educational power point.pptx
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
surgery guide for USMLE step 2-part 1.pptx
1. Basic chemist of Biomolecule (1).pptx
HIV lecture final - student.pptfghjjkkejjhhge
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
MENTAL HEALTH - NOTES.ppt for nursing students
nephrology MRCP - Member of Royal College of Physicians ppt
Neuropathic pain.ppt treatment managment
y4d nutrition and diet in pregnancy and postpartum
PEADIATRICS NOTES.docx lecture notes for medical students
neurology Member of Royal College of Physicians (MRCP).ppt
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
focused on the development and application of glycoHILIC, pepHILIC, and comm...
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
antibiotics rational use of antibiotics.pptx
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
Infections Member of Royal College of Physicians.ppt
Acid Base Disorders educational power point.pptx
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...

Detection of production of reactive oxygen

  • 1. Detection of production of Reactive Oxygen Species by SPIO Preliminary Data
  • 2. Background • Since the production of ROS in the plaque would have significant effect on the vulnerability of the plaque. • We wanted to check if the SPIO would produce ROS.
  • 3. Principle • Any event of phagocytosis is immediately followed by a transient release of super oxide due to the assembly of the NADPH oxidase against the plasma membrane. Subsequently the oxidase translocates onto the phagosomes containing the SPIO to produce intracellular ROS. • Thus an early extra cellular secretion of super oxide is detectable (using luminol) soon after phagocytosis and a later event of intracellular secretion is measurable using DCFDA dye .
  • 4. Method ∀ • The suspension of SPIO (1.25-10 uL) was added to macrophages (1x10*4/well in 96 well plates). Cells were incubated for 1 h and washed to remove extra cellular FDIO. For each dose three wells were tested. Isoluminol substrate was added and super oxide induced luminescence measured at 15, 30 and 45 min intervals using a luminometer.
  • 5. Results • SPIO was internalized by macrophages as early as 60 min after addition. • Uptake was followed by release of super oxide for all four doses tested. Super oxide was released by SPIO at all doses tested (1.25-10 ul)
  • 6. Dosage of SPIO-1.25mL 0 500 1000 1500 2000 2500 3000 3500 15min 30min 45min NOSPIO Sample1 Sample2 Sample3
  • 7. Dosage at 2.5mL 0 500 1000 1500 2000 2500 3000 3500 15min 30min 45min Sample1 Sample2 Sample3
  • 8. Dosage at 5mL 0 500 1000 1500 2000 2500 3000 15min 30min 45min Sample1 Sample2 Sample3
  • 10. Detection of intracellular ROS with DCFDA dye • Particles ingested by macrophages are enclosed within a phagosome and the NADPH oxidase assembles on these phagosomes to generate super oxide. Super oxide dismutates into hydrogen peroxide rapidly within the macrophage. This H2O2 is detected by a fluorescent dye DCFDA. DCFDA is by itself non-fluorescent. When it enters a viable cell it is hydrolyzed by esterases into DCF which is then oxidized by H2O2 to yield a green fluorescence. This is measured by fluorometer.
  • 11. Method ∀• The suspension of SPIO (1.25-10 uL) was added to macrophages (1x10*4/well in 96 well plates). Cells were incubated for 24 h and washed to remove extracellular SPIO. For each dose three wells were tested. ∀• DCFDA substrate was added and read for intracellular fluorescence using a fluorometer at 485nm/538 nm.
  • 12. Results ∀•Uptake was followed by release of H2O2 for all four doses tested. ∀•H2O2 was released by SPIO at all doses tested (1.25-10 ul/) ∀•Note untreated macrophages have a background fluorescence of < 2 AFU
  • 13. Dosage at 1.25mL 0 5 10 15 20 25 30 30min 180min Sample1 Sample2 Sample3
  • 14. Dosage of 2.5mL 0 5 10 15 20 25 30 30min 180min Sample1 Sample2 Sample3
  • 17. Detection of macrophage viability after ROS production • Viable macrophages convert the Alamar blue dye into an orange colored product measurable in a Elisa reader. AB is a widely used method to measure viability. • The hypothesis we are testing is that cells that make ROS may die and lose viability. Thus if SPIO stimulates ROS within the cells does it lead to cell death over time ??
  • 18. Method ∀ • The suspension of SPIO (1.25-10 uL) was added to macrophages (1x10*4/well in 96 well plates). Cells were incubated for 1 h or 24 h and washed to remove extracellular SPIO. For each dose three wells were tested. ∀ • AB dye at 20% volume was added to the macrophage plate and incubated for 4 h at 37o C and 5% Co2. They were read for viability using an Elisa at 570 nm
  • 19. Results • Both SPIO treated as well as untreated macrophages had same level of viability as shown in the following slide at 24 h post SPIO treatment.
  • 20. Viability values with alamar blue 0.585 0.59 0.595 0.6 0.605 0.61 0.615 0.62 0.625 0.63 1.25mL 2.5mL 5mL 10mL Untreated Sample1 Sample2 Sample3
  • 21. Future plan • As ox-LDL is know to produce ROS, we would like to see the same effect in the presence of our SPIO.